Department of Surgery, Carolinas Medical Center at Carolinas Healthcare System, Charlotte, North Carolina.
Department of Surgery, Brody School of Medicine at East Carolina University, Greenville, North Carolina.
Surg Obes Relat Dis. 2017 Aug;13(8):1347-1352. doi: 10.1016/j.soard.2017.03.024. Epub 2017 Mar 28.
Patients undergoing gastric bypass (RYGB) surgery require follow-up for efficacy assessment, early detection of postoperative complications, and also for management of co-morbid conditions. Recent literature shows support for improved long-term weight loss with close patient follow-up. However, attrition rates after RYGB have been reported as high as 50%.
The objective of this study was to assess the relationship between complete follow-up and improvement or remission of co-morbid conditions at 12 months after surgery.
University Hospital, United States.
Using the Bariatric Outcomes Longitudinal Database (BOLD) data set, patients with 12-month follow-up after RYGB were identified. Patients with complete follow-up were compared with patients who had missed either or both of their 3- and 6-month visits. Improvement and remission of type 2 diabetes, hypertension, and dyslipidemia were evaluated at 12-month postoperatively.
46,381 patients (30.6% of all RYGB patients) were identified that had follow-up with minimum 12-month data. Complete follow-up was recorded for 75.6% of this group with 12-month data. Of the 18,629 patients with type 2 diabetes at baseline, 13,498 (72.4%) and 11,287 (60.6%) had improvement and remission, respectively, at 12 months. Improvement in hypertension and dyslipidemia was noted in 17,808 (62.8%) and 11,602 (55.2%) of patients, while 13,024 (45.9%) and 9119 (43.4%) had hypertension and dyslipidemia remission, respectively. After adjusting for baseline characteristics, complete follow-up in the first year after RYGB was independently associated with a higher rate of improvement or remission of co-morbid conditions.
Complete postoperative follow-up resulted in a higher rate of co-morbidity improvement and remission compared with incomplete postoperative care. Patients and practices should strive to achieve complete and long-term follow-up after RYGB surgery.
接受胃旁路(RYGB)手术的患者需要进行随访,以评估疗效、早期发现术后并发症,并管理合并症。最近的文献表明,密切的患者随访可带来长期体重减轻的改善。然而,RYGB 后的失访率高达 50%。
本研究旨在评估手术后 12 个月时完整随访与合并症改善或缓解之间的关系。
美国大学医院。
使用减重手术结果纵向数据库(BOLD)数据集,确定 RYGB 术后有 12 个月随访的患者。将完整随访的患者与错过 3 个月或 6 个月随访的患者进行比较。在术后 12 个月时评估 2 型糖尿病、高血压和血脂异常的改善和缓解情况。
共确定了 46381 例(所有 RYGB 患者的 30.6%)有 12 个月随访数据的患者。在有 12 个月随访数据的患者中,有 75.6%的患者记录了完整随访。在基线时有 2 型糖尿病的 18629 例患者中,分别有 13498(72.4%)和 11287(60.6%)例患者在 12 个月时改善和缓解。17808(62.8%)和 11602(55.2%)例患者的高血压和血脂异常得到改善,13024(45.9%)和 9119(43.4%)例患者的高血压和血脂异常缓解。在校正基线特征后,RYGB 后第一年的完整随访与合并症改善或缓解的更高发生率独立相关。
与不完全术后护理相比,完整的术后随访导致合并症改善和缓解的更高发生率。患者和医疗机构应努力在 RYGB 手术后实现完整和长期随访。